Skip to main content
PMC home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1994 Aug 11;22(15):3181–3186. doi: 10.1093/nar/22.15.3181

The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function.

N L Chamberlain 1, E D Driver 1, R L Miesfeld 1
PMCID: PMC310294  PMID: 8065934

Abstract

Some transcription factors contain stretches of polyglutamine encoded by repeats of the trinucleotide CAG. Expansion of the CAG repeat in the androgen receptor (AR) has been correlated with the incidence and severity of X-linked spinal and bulbar muscular atrophy (Kennedy's disease). In order to understand the relationship of this mutation to AR function, we constructed ARs that varied in the position and size of the polyglutamine tract, and assayed for the abilities of these mutant receptors to bind androgen and to activate transcription of several different AR-responsive reporter genes. Elimination of the tract in both human and rat AR resulted in elevated transcriptional activation activity, strongly suggesting that the presence of the polyglutamine tract is inhibitory to transactivation. Progressive expansion of the CAG repeat in human AR caused a linear decrease of transactivation function. Importantly, expansion of the tract did not completely eliminate AR activity. We postulate that this residual AR activity may be sufficient for development of male primary and secondary sex characteristics, but may fall below a threshold level of activity necessary for normal maintenance of motor neuron function. This functional abnormality may be representative of other genetic diseases that are associated with CAG expansion mutations in open reading frames, such as spinocerebellar ataxia type I and Huntington's disease.

Full text

PDF
3181

Images in this article

3183Image
on p.3183

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler A. J., Scheller A., Hoffman Y., Robins D. M. Multiple components of a complex androgen-dependent enhancer. Mol Endocrinol. 1991 Nov;5(11):1587–1596. doi: 10.1210/mend-5-11-1587. [DOI] [PubMed] [Google Scholar]
  2. Amato A. A., Prior T. W., Barohn R. J., Snyder P., Papp A., Mendell J. R. Kennedy's disease: a clinicopathologic correlation with mutations in the androgen receptor gene. Neurology. 1993 Apr;43(4):791–794. doi: 10.1212/wnl.43.4.791. [DOI] [PubMed] [Google Scholar]
  3. Arbizu T., Santamaría J., Gomez J. M., Quílez A., Serra J. P. A family with adult spinal and bulbar muscular atrophy, X-linked inheritance and associated testicular failure. J Neurol Sci. 1983 Jun;59(3):371–382. doi: 10.1016/0022-510x(83)90022-9. [DOI] [PubMed] [Google Scholar]
  4. Beato M. Gene regulation by steroid hormones. Cell. 1989 Feb 10;56(3):335–344. doi: 10.1016/0092-8674(89)90237-7. [DOI] [PubMed] [Google Scholar]
  5. Berger S. L., Cress W. D., Cress A., Triezenberg S. J., Guarente L. Selective inhibition of activated but not basal transcription by the acidic activation domain of VP16: evidence for transcriptional adaptors. Cell. 1990 Jun 29;61(7):1199–1208. doi: 10.1016/0092-8674(90)90684-7. [DOI] [PubMed] [Google Scholar]
  6. Breedlove S. M. Cellular analyses of hormone influence on motoneuronal development and function. J Neurobiol. 1986 May;17(3):157–176. doi: 10.1002/neu.480170304. [DOI] [PubMed] [Google Scholar]
  7. Chang C. S., Kokontis J., Liao S. T. Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc Natl Acad Sci U S A. 1988 Oct;85(19):7211–7215. doi: 10.1073/pnas.85.19.7211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Danielsen M., Northrop J. P., Ringold G. M. The mouse glucocorticoid receptor: mapping of functional domains by cloning, sequencing and expression of wild-type and mutant receptor proteins. EMBO J. 1986 Oct;5(10):2513–2522. doi: 10.1002/j.1460-2075.1986.tb04529.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dieken E. S., Miesfeld R. L. Transcriptional transactivation functions localized to the glucocorticoid receptor N terminus are necessary for steroid induction of lymphocyte apoptosis. Mol Cell Biol. 1992 Feb;12(2):589–597. doi: 10.1128/mcb.12.2.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Doyu M., Sobue G., Mukai E., Kachi T., Yasuda T., Mitsuma T., Takahashi A. Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene. Ann Neurol. 1992 Nov;32(5):707–710. doi: 10.1002/ana.410320517. [DOI] [PubMed] [Google Scholar]
  11. Edwards A., Hammond H. A., Jin L., Caskey C. T., Chakraborty R. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics. 1992 Feb;12(2):241–253. doi: 10.1016/0888-7543(92)90371-x. [DOI] [PubMed] [Google Scholar]
  12. Freedman L. P., Yoshinaga S. K., Vanderbilt J. N., Yamamoto K. R. In vitro transcription enhancement by purified derivatives of the glucocorticoid receptor. Science. 1989 Jul 21;245(4915):298–301. doi: 10.1126/science.2473529. [DOI] [PubMed] [Google Scholar]
  13. Gaspar M. L., Meo T., Tosi M. Structure and size distribution of the androgen receptor mRNA in wild-type and Tfm/Y mutant mice. Mol Endocrinol. 1990 Oct;4(10):1600–1610. doi: 10.1210/mend-4-10-1600. [DOI] [PubMed] [Google Scholar]
  14. Gearing K. L., Gustafsson J. A., Okret S. Heterogeneity in the polyglutamine tract of the glucocorticoid receptor from different rat strains. Nucleic Acids Res. 1993 Apr 25;21(8):2014–2014. doi: 10.1093/nar/21.8.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gerber H. P., Seipel K., Georgiev O., Höfferer M., Hug M., Rusconi S., Schaffner W. Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science. 1994 Feb 11;263(5148):808–811. doi: 10.1126/science.8303297. [DOI] [PubMed] [Google Scholar]
  16. Giguère V., Hollenberg S. M., Rosenfeld M. G., Evans R. M. Functional domains of the human glucocorticoid receptor. Cell. 1986 Aug 29;46(5):645–652. doi: 10.1016/0092-8674(86)90339-9. [DOI] [PubMed] [Google Scholar]
  17. Godowski P. J., Picard D., Yamamoto K. R. Signal transduction and transcriptional regulation by glucocorticoid receptor-LexA fusion proteins. Science. 1988 Aug 12;241(4867):812–816. doi: 10.1126/science.3043662. [DOI] [PubMed] [Google Scholar]
  18. Goldstein L. A., Sengelaub D. R. Timing and duration of dihydrotestosterone treatment affect the development of motoneuron number and morphology in a sexually dimorphic rat spinal nucleus. J Comp Neurol. 1992 Dec 1;326(1):147–157. doi: 10.1002/cne.903260113. [DOI] [PubMed] [Google Scholar]
  19. Green H. Human genetic diseases due to codon reiteration: relationship to an evolutionary mechanism. Cell. 1993 Sep 24;74(6):955–956. doi: 10.1016/0092-8674(93)90718-6. [DOI] [PubMed] [Google Scholar]
  20. Harding A. E., Thomas P. K., Baraitser M., Bradbury P. G., Morgan-Hughes J. A., Ponsford J. R. X-linked recessive bulbospinal neuronopathy: a report of ten cases. J Neurol Neurosurg Psychiatry. 1982 Nov;45(11):1012–1019. doi: 10.1136/jnnp.45.11.1012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. He W. W., Kumar M. V., Tindall D. J. A frame-shift mutation in the androgen receptor gene causes complete androgen insensitivity in the testicular-feminized mouse. Nucleic Acids Res. 1991 May 11;19(9):2373–2378. doi: 10.1093/nar/19.9.2373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hodin R. A., Lazar M. A., Wintman B. I., Darling D. S., Koenig R. J., Larsen P. R., Moore D. D., Chin W. W. Identification of a thyroid hormone receptor that is pituitary-specific. Science. 1989 Apr 7;244(4900):76–79. doi: 10.1126/science.2539642. [DOI] [PubMed] [Google Scholar]
  23. Hoffman A., Sinn E., Yamamoto T., Wang J., Roy A., Horikoshi M., Roeder R. G. Highly conserved core domain and unique N terminus with presumptive regulatory motifs in a human TATA factor (TFIID). Nature. 1990 Jul 26;346(6282):387–390. doi: 10.1038/346387a0. [DOI] [PubMed] [Google Scholar]
  24. Hollenberg S. M., Weinberger C., Ong E. S., Cerelli G., Oro A., Lebo R., Thompson E. B., Rosenfeld M. G., Evans R. M. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature. 1985 Dec 19;318(6047):635–641. doi: 10.1038/318635a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Igarashi S., Tanno Y., Onodera O., Yamazaki M., Sato S., Ishikawa A., Miyatani N., Nagashima M., Ishikawa Y., Sahashi K. Strong correlation between the number of CAG repeats in androgen receptor genes and the clinical onset of features of spinal and bulbar muscular atrophy. Neurology. 1992 Dec;42(12):2300–2302. doi: 10.1212/wnl.42.12.2300. [DOI] [PubMed] [Google Scholar]
  26. Ingham P., Smith J. Crossing the threshold. Curr Biol. 1992 Sep;2(9):465–467. doi: 10.1016/0960-9822(92)90656-u. [DOI] [PubMed] [Google Scholar]
  27. Jenster G., van der Korput H. A., van Vroonhoven C., van der Kwast T. H., Trapman J., Brinkmann A. O. Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol Endocrinol. 1991 Oct;5(10):1396–1404. doi: 10.1210/mend-5-10-1396. [DOI] [PubMed] [Google Scholar]
  28. Kao C. C., Lieberman P. M., Schmidt M. C., Zhou Q., Pei R., Berk A. J. Cloning of a transcriptionally active human TATA binding factor. Science. 1990 Jun 29;248(4963):1646–1650. doi: 10.1126/science.2194289. [DOI] [PubMed] [Google Scholar]
  29. Kennedy W. R., Alter M., Sung J. H. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology. 1968 Jul;18(7):671–680. doi: 10.1212/wnl.18.7.671. [DOI] [PubMed] [Google Scholar]
  30. Kujawa K. A., Kinderman N. B., Jones K. J. Testosterone-induced acceleration of recovery from facial paralysis following crush axotomy of the facial nerve in male hamsters. Exp Neurol. 1989 Jul;105(1):80–85. doi: 10.1016/0014-4886(89)90174-x. [DOI] [PubMed] [Google Scholar]
  31. La Spada A. R., Roling D. B., Harding A. E., Warner C. L., Spiegel R., Hausmanowa-Petrusewicz I., Yee W. C., Fischbeck K. H. Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nat Genet. 1992 Dec;2(4):301–304. doi: 10.1038/ng1292-301. [DOI] [PubMed] [Google Scholar]
  32. La Spada A. R., Wilson E. M., Lubahn D. B., Harding A. E., Fischbeck K. H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991 Jul 4;352(6330):77–79. doi: 10.1038/352077a0. [DOI] [PubMed] [Google Scholar]
  33. Levine M., Manley J. L. Transcriptional repression of eukaryotic promoters. Cell. 1989 Nov 3;59(3):405–408. doi: 10.1016/0092-8674(89)90024-x. [DOI] [PubMed] [Google Scholar]
  34. Lubahn D. B., Joseph D. R., Sullivan P. M., Willard H. F., French F. S., Wilson E. M. Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science. 1988 Apr 15;240(4850):327–330. doi: 10.1126/science.3353727. [DOI] [PubMed] [Google Scholar]
  35. Matsuura T., Demura T., Aimoto Y., Mizuno T., Moriwaka F., Tashiro K. Androgen receptor abnormality in X-linked spinal and bulbar muscular atrophy. Neurology. 1992 Sep;42(9):1724–1726. doi: 10.1212/wnl.42.9.1724. [DOI] [PubMed] [Google Scholar]
  36. McPhaul M. J., Marcelli M., Tilley W. D., Griffin J. E., Wilson J. D. Androgen resistance caused by mutations in the androgen receptor gene. FASEB J. 1991 Nov;5(14):2910–2915. doi: 10.1096/fasebj.5.14.1752359. [DOI] [PubMed] [Google Scholar]
  37. Mhatre A. N., Trifiro M. A., Kaufman M., Kazemi-Esfarjani P., Figlewicz D., Rouleau G., Pinsky L. Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nat Genet. 1993 Oct;5(2):184–188. doi: 10.1038/ng1093-184. [DOI] [PubMed] [Google Scholar]
  38. Miesfeld R., Godowski P. J., Maler B. A., Yamamoto K. R. Glucocorticoid receptor mutants that define a small region sufficient for enhancer activation. Science. 1987 Apr 24;236(4800):423–427. doi: 10.1126/science.3563519. [DOI] [PubMed] [Google Scholar]
  39. Mooradian A. D., Morley J. E., Korenman S. G. Biological actions of androgens. Endocr Rev. 1987 Feb;8(1):1–28. doi: 10.1210/edrv-8-1-1. [DOI] [PubMed] [Google Scholar]
  40. Orr H. T., Chung M. Y., Banfi S., Kwiatkowski T. J., Jr, Servadio A., Beaudet A. L., McCall A. E., Duvick L. A., Ranum L. P., Zoghbi H. Y. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet. 1993 Jul;4(3):221–226. doi: 10.1038/ng0793-221. [DOI] [PubMed] [Google Scholar]
  41. Palca J. Genome projects are growing like weeds. Science. 1989 Jul 14;245(4914):131–131. doi: 10.1126/science.2749252. [DOI] [PubMed] [Google Scholar]
  42. Palvimo J. J., Kallio P. J., Ikonen T., Mehto M., Jänne O. A. Dominant negative regulation of trans-activation by the rat androgen receptor: roles of the N-terminal domain and heterodimer formation. Mol Endocrinol. 1993 Nov;7(11):1399–1407. doi: 10.1210/mend.7.11.8114755. [DOI] [PubMed] [Google Scholar]
  43. Pearce D., Yamamoto K. R. Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science. 1993 Feb 19;259(5098):1161–1165. doi: 10.1126/science.8382376. [DOI] [PubMed] [Google Scholar]
  44. Ptashne M., Gann A. A. Activators and targets. Nature. 1990 Jul 26;346(6282):329–331. doi: 10.1038/346329a0. [DOI] [PubMed] [Google Scholar]
  45. Rennie P. S., Bruchovsky N., Leco K. J., Sheppard P. C., McQueen S. A., Cheng H., Snoek R., Hamel A., Bock M. E., MacDonald B. S. Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. Mol Endocrinol. 1993 Jan;7(1):23–36. doi: 10.1210/mend.7.1.8446105. [DOI] [PubMed] [Google Scholar]
  46. Richards R. I., Sutherland G. R. Dynamic mutations: a new class of mutations causing human disease. Cell. 1992 Sep 4;70(5):709–712. doi: 10.1016/0092-8674(92)90302-s. [DOI] [PubMed] [Google Scholar]
  47. Rosenthal N. Identification of regulatory elements of cloned genes with functional assays. Methods Enzymol. 1987;152:704–720. doi: 10.1016/0076-6879(87)52075-4. [DOI] [PubMed] [Google Scholar]
  48. Rundlett S. E., Gordon D. A., Miesfeld R. L. Characterization of a panel of rat ventral prostate epithelial cell lines immortalized in the presence or absence of androgens. Exp Cell Res. 1992 Nov;203(1):214–221. doi: 10.1016/0014-4827(92)90057-f. [DOI] [PubMed] [Google Scholar]
  49. Rundlett S. E., Wu X. P., Miesfeld R. L. Functional characterizations of the androgen receptor confirm that the molecular basis of androgen action is transcriptional regulation. Mol Endocrinol. 1990 May;4(5):708–714. doi: 10.1210/mend-4-5-708. [DOI] [PubMed] [Google Scholar]
  50. Schneuwly S., Kuroiwa A., Baumgartner P., Gehring W. J. Structural organization and sequence of the homeotic gene Antennapedia of Drosophila melanogaster. EMBO J. 1986 Apr;5(4):733–739. doi: 10.1002/j.1460-2075.1986.tb04275.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Seipel K., Georgiev O., Schaffner W. Different activation domains stimulate transcription from remote ('enhancer') and proximal ('promoter') positions. EMBO J. 1992 Dec;11(13):4961–4968. doi: 10.1002/j.1460-2075.1992.tb05603.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Simental J. A., Sar M., Lane M. V., French F. S., Wilson E. M. Transcriptional activation and nuclear targeting signals of the human androgen receptor. J Biol Chem. 1991 Jan 5;266(1):510–518. [PubMed] [Google Scholar]
  53. Sobue G., Doyu M., Morishima T., Mukai E., Yasuda T., Kachi T., Mitsuma T. Aberrant androgen action and increased size of tandem CAG repeat in androgen receptor gene in X-linked recessive bulbospinal neuronopathy. J Neurol Sci. 1994 Feb;121(2):167–171. doi: 10.1016/0022-510x(94)90347-6. [DOI] [PubMed] [Google Scholar]
  54. Studier F. W., Rosenberg A. H., Dunn J. J., Dubendorff J. W. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 1990;185:60–89. doi: 10.1016/0076-6879(90)85008-c. [DOI] [PubMed] [Google Scholar]
  55. Supakar P. C., Song C. S., Jung M. H., Slomczynska M. A., Kim J. M., Vellanoweth R. L., Chatterjee B., Roy A. K. A novel regulatory element associated with age-dependent expression of the rat androgen receptor gene. J Biol Chem. 1993 Dec 15;268(35):26400–26408. [PubMed] [Google Scholar]
  56. Tan J. A., Joseph D. R., Quarmby V. E., Lubahn D. B., Sar M., French F. S., Wilson E. M. The rat androgen receptor: primary structure, autoregulation of its messenger ribonucleic acid, and immunocytochemical localization of the receptor protein. Mol Endocrinol. 1988 Dec;2(12):1276–1285. doi: 10.1210/mend-2-12-1276. [DOI] [PubMed] [Google Scholar]
  57. Trapman J., Klaassen P., Kuiper G. G., van der Korput J. A., Faber P. W., van Rooij H. C., Geurts van Kessel A., Voorhorst M. M., Mulder E., Brinkmann A. O. Cloning, structure and expression of a cDNA encoding the human androgen receptor. Biochem Biophys Res Commun. 1988 May 31;153(1):241–248. doi: 10.1016/s0006-291x(88)81214-2. [DOI] [PubMed] [Google Scholar]
  58. Umesono K., Murakami K. K., Thompson C. C., Evans R. M. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell. 1991 Jun 28;65(7):1255–1266. doi: 10.1016/0092-8674(91)90020-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Wharton K. A., Yedvobnick B., Finnerty V. G., Artavanis-Tsakonas S. opa: a novel family of transcribed repeats shared by the Notch locus and other developmentally regulated loci in D. melanogaster. Cell. 1985 Jan;40(1):55–62. doi: 10.1016/0092-8674(85)90308-3. [DOI] [PubMed] [Google Scholar]
  60. Yu W. H. Administration of testosterone attenuates neuronal loss following axotomy in the brain-stem motor nuclei of female rats. J Neurosci. 1989 Nov;9(11):3908–3914. doi: 10.1523/JNEUROSCI.09-11-03908.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES